Nanosonics Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NNCSF research report →
Companywww.nanosonics.com.au
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution.
- CEO
- Michael C. Kavanagh
- IPO
- 2012
- Employees
- 466
- HQ
- Macquarie Park, NSW, AU
Price Chart
Valuation
- Market Cap
- $747.05M
- P/E
- 49.21
- P/S
- 4.80
- P/B
- 4.61
- EV/EBITDA
- 29.08
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 77.17%
- Op Margin
- 8.95%
- Net Margin
- 9.91%
- ROE
- 9.57%
- ROIC
- 7.04%
Growth & Income
- Revenue
- $198.93M · 17.01%
- Net Income
- $20.68M · 59.39%
- EPS
- $0.07 · 62.38%
- Op Income
- $8.93M
- FCF YoY
- 73.99%
Performance & Tape
- 52W High
- $3.30
- 52W Low
- $2.14
- 50D MA
- $2.70
- 200D MA
- $2.73
- Beta
- 1.21
- Avg Volume
- 188
Get TickerSpark's AI analysis on NNCSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NNCSF Coverage
We haven't published any research on NNCSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NNCSF Report →